http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct
Kourtesakis, A. (First author)DKFZ* ; Hannah Chow, H. N.DKFZ* ; Bailey, E.DKFZ* ; Horschitz, S. ; Jabali, A. ; Will, R.DKFZ* ; Schifflers, C.DKFZ* ; Suwala, A. K.DKFZ* ; Rohdjess, H.DKFZ* ; Hahn, M.DKFZ* ; Chih, Y.-C.DKFZ* ; Hai, L.DKFZ* ; Reibold, D.DKFZ* ; Pusch, S.DKFZ* ; Fischer, M. ; Sinn, R. ; Agardy, D. A.DKFZ* ; Frieder Hoffmann, D. C.DKFZ* ; Breckwoldt, M. O. ; Wagener, R.DKFZ* ; Kaulen, L.DKFZ* ; Koch, P. ; von Deimling, A.DKFZ* ; Bunse, L.DKFZ* ; Platten, M.DKFZ* ; Sahm, F.DKFZ* ; Müller-Tidow, C. ; Schmitt, M. ; Wick, W.DKFZ* ; Sauer, T. ; Kessler, T. (Last author)DKFZ*
2026
Elsevier
[New York]
Note: Molecular Therapy Oncology 2950-3299 / #EA:B320#LA:B320#
Contributing Institute(s):
- KKE Neuroonkologie (B320)
- DKTK HD zentral (HD01)
- Zelluläre Tools (W111)
- Immuntherapie und -prävention (D410)
- KKE Neuropathologie (B300)
- KKE Neuroimmunologie und Hirntumorimmunologie (D170)
Research Program(s):
- 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)
Appears in the scientific report
2026